Literature DB >> 2049310

The management of follicular lymphoma.

T A Lister1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2049310     DOI： 10.1007/978-1-4899-7305-4_20

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  8 in total

1.  Modelling intervention effects after cancer relapses.

Authors:  Juan R González; Edsel A Peña; Elizabeth H Slate
Journal:  Stat Med       Date:  2005-12-30       Impact factor: 2.373

2.  Alkylating DNA damage stimulates a regulated form of necrotic cell death.

Authors:  Wei-Xing Zong; Dara Ditsworth; Daniel E Bauer; Zhao-Qi Wang; Craig B Thompson
Journal:  Genes Dev       Date:  2004-05-14       Impact factor: 11.361

3.  A British National Lymphoma Investigation randomised trial of single agent chlorambucil plus radiotherapy versus radiotherapy alone in low grade, localised non-Hodgkins lymphoma.

Authors:  S M Kelsey; A C Newland; G V Hudson; A M Jelliffe
Journal:  Med Oncol       Date:  1994       Impact factor: 3.064

4.  MLH1 mediates PARP-dependent cell death in response to the methylating agent N-methyl-N-nitrosourea.

Authors:  J R McDaid; J Loughery; P Dunne; J C Boyer; C S Downes; R A Farber; C P Walsh
Journal:  Br J Cancer       Date:  2009-07-21       Impact factor: 7.640

Review 5.  Rituximab for the first-line maintenance treatment of follicular non-Hodgkin's lymphoma : a NICE single technology appraisal.

Authors:  Janette Greenhalgh; Adrian Bagust; Angela Boland; Michaela Blundell; James Oyee; Sophie Beale; Yenal Dundar; Juliet Hockenhull; Chris Proudlove; Patrick Chu
Journal:  Pharmacoeconomics       Date:  2013-05       Impact factor: 4.981

6.  Pilot phase I/II study of new salvage therapy (CHASE) for refractory or relapsed malignant lymphoma.

Authors:  Michinori Ogura; Yoshitoyo Kagami; Hirofumi Taji; Ritsuro Suzuki; Kazuhisa Miura; Takahiro Takeuchi; Yasuo Morishima
Journal:  Int J Hematol       Date:  2003-06       Impact factor: 2.319

7.  Mediastinal large-cell lymphoma with sclerosis (MLCLS).

Authors:  A Z Rohatiner; J S Whelan; R K Ganjoo; A J Norton; A Wilson; T A Lister
Journal:  Br J Cancer       Date:  1994-03       Impact factor: 7.640

Review 8.  Corrupting the DNA damage response: a critical role for Rad52 in tumor cell survival.

Authors:  Rachel Lieberman; Ming You
Journal:  Aging (Albany NY)       Date:  2017-07-15       Impact factor: 5.682
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.